The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: -1.00 (-0.13%)
Spread: 0.20 (0.027%)
Open: 756.00
High: 767.00
Low: 748.00
Prev. Close: 756.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Presentation of Financial Information

6 Apr 2021 11:45

RNS Number : 5105U
Standard Chartered PLC
06 April 2021
 

STANDARD CHARTERED PLC

PRESENTATION OF FINANCIAL INFORMATION

 

As announced on 10 September 2020, Standard Chartered PLC (the Group) updated its organisation structure effective on 1 January 2021 as part of the ongoing execution of its refreshed strategy. The Group is also aligning the external reporting of some of its products with how they are managed under the new organisation structure. To aid comparisons with prior periods at its results for the first quarter of 2021 to be published on 29 April 2021, the Group has today made available on its website (Investors) financial information reflecting the new organisation structure and product classification for the past eight quarters:

· Private Banking and Retail Banking: The two client segments that serve individual and business banking clients have been combined to form a single Consumer, Private & Business Banking segment

· Corporate & Institutional Banking and Commercial Banking: The two client segments that serve larger companies and institutions have been combined to form a single Corporate, Commercial & Institutional Banking segment

· Greater China & North Asia and ASEAN & South Asia: These two regions have been combined to form a single Asia region

For reporting purposes, the combination of segments and regions requires a simple addition of the respective financial results. Any further changes in the second quarter of 2021 resulting from the final allocation of smaller business clients between segments will be noted at the Group's half-year results but are not expected to be material.

The Group's Financial Markets business that serves the Corporate, Commercial & Institutional Banking segment has been expanded and reorganised, and going forward its income will be reported on the following basis:

· Macro Trading: Many of the Group's clients require seamless coverage in relation to financial instruments that are sensitive to macroeconomic indicators. Integrating the management of Rates, FX and Commodities helps to satisfy this demand in the most efficient manner possible, and the external reporting will align to this view

· Credit Markets: The Group has integrated the majority of its Corporate Finance business within Financial Markets. This will enable it to provide a tailored solution to clients seeking to originate financing combined with the insight and liquidity of the secondary market-making business. This will be broken down for reporting purposes into:

o Credit Trading: Provides liquidity to clients in the secondary markets. Reporting income from this activity separately will allow investors to combine it with Macro Trading income, which is often reported in aggregate as 'FICC' by other market participants

o Financing Solutions and Issuance: Provides tailored financing solutions that includes project and export finance, event-driven financing, leveraged finance, bond and loan syndication and bespoke financing

· Structured Finance: Provides financing and leasing services to the transportation sector

· Financing and Security Services: Provides custody, prime brokerage, clearing and money markets services, and includes income deriving from credit and funding valuation adjustments

· Debit valuation adjustment (DVA): Adjustments to the fair value of derivative contracts that reflect the possibility that the Group may default and not pay the full market value of contracts

The remaining elements of the Group's Corporate Finance business - primarily M&A Advisory - have been transferred into Lending and Portfolio Management, integrating merger and acquisition capabilities across the broader coverage organisation.

The re-presentation summarised above has not resulted in any changes to the reported income or balances in total at a Group level.

 

For further information, please contact:

Gregg Powell, Head of Investor Relations: +852 2820 3282

Adnan Akhtar, Head of Sell-Side Investor Relations: +44 (0) 20 7885 7255

Julie Gibson, Head of Media Relations: +44 (0) 20 7885 2434

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBGGDSRXGDGBL
Date   Source Headline
2nd May 20242:25 pmRNSQ1 2024 Pillar 3 Disclosures
2nd May 20242:06 pmRNSPublication of Supplementary Prospectus
2nd May 20247:00 amRNS1st Quarter Results
1st May 20245:40 pmRNSTransaction in Own Shares
1st May 202412:20 pmRNSNotice of Redemption
1st May 202410:03 amRNSTotal Voting Rights
30th Apr 20245:36 pmRNSTransaction in Own Shares
29th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20245:30 pmRNSTransaction in Own Shares
26th Apr 202410:17 amRNSOverseas Regulatory Announcement
25th Apr 20245:50 pmRNSTransaction in Own Shares
24th Apr 20246:25 pmRNSPublication of a Prospectus
24th Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.